Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Ulta Beauty Receives Moderate Buy Rating from Analysts with Potential Upside

Elaine Mendonca by Elaine Mendonca
February 14, 2024
in Breaking News
0
Retail Stock Bull Market
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

As of February 14, 2024, a recent analysis of Ulta Beauty (NASDAQ: ULTA) conducted by 13 analysts reveals a diverse range of opinions, with the majority leaning towards a somewhat bullish outlook. Over the past three months, the breakdown of ratings is as follows:

Bullish: 3
Somewhat Bullish: 7
Indifferent: 2
Somewhat Bearish: 1
Bearish: 0

In the last 30 days, there has been one indifferent rating, with no new bullish or bearish ratings. The average 12-month price target among analysts stands at $529.77, with a high estimate of $600.00 and a low estimate of $400.00. Notably, this average has experienced a 5.3% increase from the previous target of $503.10.

Recent updates from various analysts regarding their ratings and price targets for Ulta Beauty include:

– Anthony Chukumba from Loop Capital maintains a hold rating with a price target of $530.00.
– Kristina Ruggeri of Argus Research has upgraded the stock to a buy rating with a target of $545.00, up from $500.00.
– Christopher Horvers from JP Morgan has also upgraded the stock to overweight with a target of $535.00, up from $505.00.
– Rupesh Parikh of Oppenheimer maintains an outperform rating with a target of $525.00.
– Mark Altschwager from Baird has upgraded the stock to outperform with a target of $560.00, up from $550.00.
– Michael Lasser of UBS has upgraded the stock to buy with a target of $575.00, up from $560.00.
– Korinne Wolfmeyer at Piper Sandler has upgraded the stock to overweight with a target of $572.00, up from $540.00.
– Michael Baker from DA Davidson has upgraded the stock to buy with a target of $530.00, up from $495.00.
– Ike Boruchow of Wells Fargo has upgraded the stock to underweight with a target of $400.00, up from $375.00.
– Kelly Crago of Citigroup has upgraded the stock to neutral with a target of $485.00, up from $440.00.

Overall, analysts’ consensus leans towards a Moderate Buy rating for Ulta Beauty, with a 12-month average price target of $545.20. This suggests a potential upside from the current price.

ULTA Beauty Inc. (ULTA) Stock Price Shows Slight Drop on February 14, 2024: Analysis and Considerations for Investors

On February 14, 2024, ULTA Beauty Inc. (ULTA) experienced a slight drop in its stock price. The stock opened at $531.68, which was $0.62 higher than its previous closing price. However, throughout the day, the stock price decreased by $5.55, representing a 1.05% drop.

Despite this drop, ULTA’s stock performance remains strong. The stock is currently trading near the top of its 52-week range and above its 200-day simple moving average, suggesting positive price momentum.

The fact that ULTA is trading near the top of its 52-week range indicates that investors have been optimistic about the company’s prospects. It suggests that ULTA has been able to deliver strong financial results and meet or exceed market expectations. This positive sentiment is further supported by the stock’s position above its 200-day simple moving average, indicating an upward trend in the long term.

However, the slight drop in ULTA’s stock price on February 14 could be attributed to various factors. It is important to note that stock prices can fluctuate on a daily basis, and short-term price movements may not necessarily reflect the overall health or potential of a company.

Investors should consider analyzing ULTA’s financial performance, industry trends, and any relevant news or events that may impact the company’s future prospects. It is also advisable to consult with a financial advisor or conduct thorough research before making any investment decisions.

In conclusion, ULTA’s stock performance on February 14, 2024, showed a slight drop in price. However, the stock remains strong overall, trading near the top of its 52-week range and above its 200-day simple moving average. Investors should consider a comprehensive analysis of the company’s financials and market conditions before making any investment decisions.

ULTA Beautys Stock Performance on February 14, 2024: A Steady Growth Amidst Quarterly Challenges

Title: ULTA Beauty’s Stock Performance on February 14, 2024: A Steady Growth Amidst Quarterly Challenges

Introduction:
On February 14, 2024, ULTA Beauty’s stock performance showcased a consistent growth trajectory, with the company’s total revenue and net income experiencing positive year-over-year (YoY) changes. However, the quarterly results presented some challenges, as the net income and earnings per share (EPS) witnessed a decline. This article will delve into ULTA Beauty’s financial performance, highlighting the key figures and discussing the implications for investors.

Total Revenue Growth:
ULTRA Beauty’s total revenue for the past year stood at $10.21 billion, reflecting a notable YoY increase of 18.28%. However, the total revenue remained flat in the last quarter, standing at $2.49 billion.

Net Income Performance:
ULTRA Beauty’s net income witnessed a substantial YoY increase of 26.03%, reaching $1.24 billion. However, the net income experienced a decline of 16.87% since the previous quarter, amounting to $249.48 million.

Earnings per Share:
ULTRA Beauty’s earnings per share (EPS) witnessed a significant YoY increase of 33.58%, standing at $24.01. However, the EPS declined by 15.82% since the last quarter, amounting to $5.07.

Conclusion:
Overall, ULTA Beauty’s stock performance on February 14, 2024, showcased a positive trend in terms of YoY growth in total revenue, net income, and earnings per share. However, the quarterly results presented some challenges, with a decline in net income and earnings per share. Investors should carefully evaluate the reasons behind these declines to assess the long-term implications for ULTA Beauty’s financial health and make informed investment decisions.

Tags: ULTA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Industrial Metals and Mining stock Trading

Agnico Eagle Mines Quarterly Earnings Report Impact on Investor Sentiment and Stock Prices

Healthcare-IT-and-tech

ENDRA Life Sciences Inc Expands Intellectual Property Portfolio with Three New Patents for TAEUS System

Eastman and Dentis Group Revolutionizing Recycling with Mechanical and Molecular Processes

Recommended

SKYX Platforms Stock

Marriott Partnership Signals Major Breakthrough for SKYX Platforms

5 months ago
Microsoft Stock

Microsoft’s AI Ambition: A High-Stakes Bet on Future Growth

18 hours ago
Turtle Beach Stock

Turtle Beach Forges PlayStation Alliance with New Gaming Headset

5 months ago
FLO stock news

Cemtrex Shares Surge After Halting Trading Due to Circuit Breaker

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Fossil Group Stock Surges Past Key Technical Threshold

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Trending

Rolls Royce Stock
Defense & Aerospace

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

by Dieter Jaworski
February 5, 2026
0

The coming weeks represent a critical juncture for Rolls-Royce. The company is poised to demonstrate whether it...

Viking Therapeutics Stock

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026
Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026
CureVac Stock

CureVac Delisted Following BioNTech Acquisition Completion

February 5, 2026
EOS Stock

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rolls-Royce Shares: A Pivotal Period for Growth and Diversification
  • Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report
  • Solana Faces Billions in Potential Token Supply Releases

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com